Results 171 to 180 of about 1,662 (181)

Subconjunctival bevacizumab for corneal neovascularization

Acta Ophthalmologica, 2010
Samar F Farid
exaly  

The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema

Current Eye Research, 2020
Volkan Yeter, Özlem Eski Yücel
exaly  

Subconjunctival bevacizumab in the impending recurrent pterygia

International Ophthalmology, 2013
Sezin Akca Bayar, Cem Kucukerdonmez, Yonca Aydin áková   +2 more
exaly  

Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1‐year follow‐up

Clinical and Experimental Ophthalmology, 2014
Yonathan Garfias
exaly  

Subconjunctival bevacizumab for corneal neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology, 2007
Mesut Erdurmuş, Yuksel Totan
exaly  

Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse

Cutaneous and Ocular Toxicology, 2011
Constantine D Georgakopoulos, Olga E Makri, Nikolaos Pharmakakis   +2 more
exaly  

Intrastromal and subconjunctival injection of bevacizumab for the treatment of corneal neovascularisation in children

2018
Yeo, Damien, Moore, William
openaire   +1 more source

Pterygia: Pathogenesis and the Role of Subconjunctival Bevacizumab in Treatment

Seminars in Ophthalmology, 2009
C Stephen Foster
exaly  

Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits

2009
Fumio Shiraga, Noriyuki Kuno, Shinobu Fujii   +2 more
exaly  

[Subconjunctival injection of bevacizumab for treatment of corneal neovascularization after perforating keratoplasty].

Klinische Monatsblatter fur Augenheilkunde, 2009
M M, Maier, A, Erben, R, Khoramnia, D, Zapp, C, Winkler von Mohrenfels, C, Lohmann   +5 more
openaire   +1 more source